Johnson & Johnson

Johnson & Johnson said Tuesday that it will offer at least $8.9 billion to resolve thousands of lawsuits filed by people alleging that the company's products containing talc caused cancer, quadrupling…

Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare autoimmune diseases, in a deal valued at $26.4 billion. Each Horizon shareholder will receive $116.50 per share for each share…